NIAID Banner Logo Image

HIV Citation List: December 5 - December 18, 2014

PubMed citations

1. Myristoylated Derivatives of 2',3'-Didehydro-2',3'-dideoxythymidine (Stavudine) Bi-functional Prodrugs with Potent anti-HIV-1 Activity and Low Cytotoxicity. Singh, R.K., A. Miazga, A. Dabrowska, A. Lipniacki, A. Piasek, T. Kulikowski, and D. Shugar. Antiviral Chemistry & Chemotherapy, 2014. 23(6): p. 231-235. PMID[23985753].
[PubMed]. HIV_1205-121814.


2. Indolylarylsulfones Carrying a Heterocyclic Tail as Very Potent and Broad Spectrum HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Famiglini, V., G. La Regina, A. Coluccia, S. Pelliccia, A. Brancale, G. Maga, E. Crespan, R. Badia, E. Riveira-Munoz, J.A. Este, R. Ferretti, R. Cirilli, C. Zamperini, M. Botta, D. Schols, V. Limongelli, B. Agostino, E. Novellino, and R. Silvestri. Journal of Medicinal Chemistry, 2014. 57(23): p. 9945-9957. PMID[25418038].
[PubMed]. HIV_1205-121814.

ISI Web of Knowledge Citations

3. Altertoxins with Potent anti-HIV Activity from Alternaria tenuissima QUE1Se, a Fungal Endophyte of Quercus emoryi. Bashyal, B.P., B.P. Wellensiek, R. Ramakrishnan, S.H. Faeth, N. Ahmad, and A.A.L. Gunatilaka. Bioorganic & Medicinal Chemistry, 2014. 22(21): p. 6112-6116. ISI[000344471800039].

[WOS]. HIV_1205-121814.


4. A Novel Laccase with Potent Antiproliferative and HIV-1 Reverse Transcriptase Inhibitory Activities from Mycelia of Mushroom Coprinus comatus. Zhao, S., C.B. Rong, C. Kong, Y. Liu, F. Xu, Q.J. Miao, S.X. Wang, H.X. Wang, and G.Q. Zhang. Biomed Research International, 2014. ISI[000345039600001].
[WOS]. HIV_1205-121814.


5. Combination of the CCL5-derived Peptide R4.0 with Different HIV-1 Blockers Reveals Wide Target Compatibility and Synergic Cobinding to CCR5. Secchi, M., L. Vassena, S. Morin, D. Schols, and L. Vangelista. Antimicrobial Agents and Chemotherapy, 2014. 58(10): p. 6215-6223. ISI[000344157500068].
[WOS]. HIV_1205-121814.


6. Design, Synthesis and Activity Prescreening of Small Molecule-peptide Conjugates as HIV-1 Fusion Inhibitors Targeting gp41. Liang, G.D., C. Wang, W.G. Shi, K. Wang, X.F. Jiang, X.Y. Xu, and K.L. Liu. Chemical Journal of Chinese Universities, 2014. 35(10): p. 2100-2103. ISI[000344833200008].
[WOS]. HIV_1205-121814.


7. CPI-431-32, a Novel Cyclophilin A Inhibitor, Simultaneously Blocks Replication of HCV and HIV-1 Viruses in a Novel in Vitro Co-infection Model. Gallay, P., M. Bobardt, D. Trepanier, D. Ure, C. Ordonez, and R.T. Foster. Hepatology, 2014. 60: p. 1128A-1128A. ISI[000344483804489].
[WOS]. HIV_1205-121814.


8. Serendipitous Discovery of 2-((Phenylsulfonyl) methyl)-thieno[3,2-d]pyrimidine Derivatives as Novel HIV-1 Replication Inhibitors. Kim, J., J. Kwon, D. Lee, S. Jo, D.S. Park, J. Choi, E. Park, J.Y. Hwang, Y. Ko, I. Choi, M.K. Ju, J. Ahn, J. Kim, S.J. Han, T.H. Kim, J. Cechetto, J. Nam, S. Ahn, P. Sommer, M. Liuzzi, and J. Lee. Bioorganic & Medicinal Chemistry Letters, 2014. 24(23): p. 5473-5477. ISI[000345125500027].

[WOS]. HIV_1205-121814.


9. Synthesis and Antiviral Evaluation of 2-Amino-6-carbamoylpurine Dioxolane Nucleoside Derivatives and Their Phosphoramidates Prodrugs. Cho, J.H., L. Bondana, M.A. Detorio, C. Montero, L.C. Bassit, F. Amblard, S.J. Coats, and R.F. Schinazi. Bioorganic & Medicinal Chemistry, 2014. 22(23): p. 6665-6671. ISI[000345287300013].

[WOS]. HIV_1205-121814.


10. Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl phenyl ethers. Lee, W.G., K.M. Frey, R. Gallardo-Macias, K.A. Spasov, M. Bollini, K.S. Anderson, and W.L. Jorgensen. ACS Medicinal Chemistry Letters, 2014. 5(11): p. 1259-1262. ISI[000344977100020].

[WOS]. HIV_1205-121814.


11. Synthesis and anti-HIV-1 Activity of Olean-9(11),12(13)-dien-30-oic acid 3[beta]-(2-O-[beta]-D-Glucuronopyranosyl-[beta]-D-glucuronopyranoside). Baltina, L.A., O.V. Stolyarova, R.M. Kondratenko, T.M. Gabbasov, L.A. Baltina, O.A. Plyasunova, and T.V. Il'ina. Pharmaceutical Chemistry Journal, 2014. 48(7): p. 439-443. ISI[000345317700005].

[WOS]. HIV_1205-121814.

Patent Citations

12. Aptamers that Bind HIV-1 5'UTR, Methods and Compositions for Production and Therapeutic Uses. Berzal Herranz, A., C. Briones Llorente, F.J. Sanchez-Luque, S. Cuevas Manrubia, and M. Stich. Patent. 2014. 2012-31819 2471670: 64pp.

[Patent]. HIV_1205-121814.


13. Fused Tricyclic Heterocyclic Compounds as HIV Integrase Inhibitors and Their Preparation and Use for the Treatment of HIV Infection. Coleman, P.J., T.J. Hartingh, I.T. Raheem, J. Schreier, J.T. Sisko, J. Wai, T. Graham, L. Hu, and X. Peng. Patent. 2014. 2014-CN75685 2014183532: 115pp.

[Patent]. HIV_1205-121814.


14. Preparation of Pyrazole Derivatives for the Treatment of HIV Virus Infection. Kato, T., A. Hirai, M. Matsuoka, and K. Shimura. Patent. 2014. 2013-92023 2014214118: 64pp.

[Patent]. HIV_1205-121814.


15. Combination Therapy Using Vif Inhibitor and an Apobec3g (A3g) Activator for Treating HIV Infection and AIDS Disease. Smith, H.C., R.P. Bennett, and K. Prohaska. Patent. 2014. 2014-US37935 2014186423: 74pp.

[Patent]. HIV_1205-121814.


16. Compounds for Inhibiting Drug-resistant Strains of HIV-1 Integrase. Zhao, X.Z., S. Smith, M.A. Metifiot, B. Johnson, C. Marchand, S. Hughes, Y. Pommier, and T.R. Burke. Patent. 2014. 2014-US37905 2014186398: 107pp.

[Patent]. HIV_1205-121814.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021